ABOUT CONOLIDINE

These final results, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the thought of targeting ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected Conditions.These benefits suggest that conolidine